|
0
|
|
Modulating the VIP-VIPR pathway reprograms CAR T cells for superior antitumor efficacy in preclinical cancer models.
(science.org)
|
Lin HK
…
Rafiq S
Science Translational Medicine
2026-07-22
|
#car-t
#cancer
#immunotherapy
#t cell engineering
#neuropeptide
|
|
0
|
|
Single-nucleus multimodal spatial transcriptomics reveals spatial colocalization of neoantigen-expressing tumor cells and cognate T cells.
(nature.com)
|
Nagler A
…
Wu CJ
Nature Biotechnology
2026-07-22
|
#transcriptomics
#immunotherapy
#neoantigens
#cancer
|
|
0
|
|
Lipids in ovarian cancer ascites impair T cell activation by disrupting TCR dynamics.
(nature.com)
|
Brown EG
…
O'Connor RS
Nature Metabolism
2026-07-22
|
#lipidomics
#ovarian cancer
#immunity
#immunotherapy
#tumor microenvironment
|
|
0
|
|
Efficacy and biomarker exploration of anlotinib plus penpulimab in second-line ES-SCLC: Results from the phase 2 ALTER-L041 trial.
(linkinghub.elsevier.com)
|
Zeng L
…
Zhang Y
Cell Reports Medicine
2026-07-22
|
#clinical trial
#immunotherapy
#lung cancer
#biomarker
#ctdna
|
|
0
|
|
A poly(I:C)/QS-21-based in situ vaccine synergizes with anti-PD-1 therapy to overcome tumor immunoresistance.
(linkinghub.elsevier.com)
|
Zhang W
…
Li X
Cell Reports Medicine
2026-07-22
|
#cancer
#immunotherapy
#adjuvant
#vaccination
#immunity
|
|
0
|
|
Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy.
(linkinghub.elsevier.com)
|
Yao L
…
Deng G
Cell Reports Medicine
2026-07-22
|
#immunotherapy
#cuproptosis
#melanoma
#immunogenicity
#cell death
|
|
0
|
|
Safety and efficacy of low-dose, cord blood-derived CD19 CAR-NK cells with 4-1BB co-stimulation in refractory systemic lupus erythematosus.
(linkinghub.elsevier.com)
|
Zeng Z
…
Wu H
Cell Med
2026-07-22
|
#lupus
#car-nk
#immunotherapy
#cell therapy
#autoimmune
|
|
0
|
|
FcRH5xCD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.
(nature.com)
|
Cohen AD
…
Krishnan A
Nature Medicine
2026-07-22
|
#immunotherapy
#myeloma
#bispecific-antibodies
#clinical trial
#oncology
|
|
0
|
|
Tumor-specific antibodies elicited by engineered bacteria promote bladder cancer immunotherapy in preclinical mouse models.
(science.org)
|
Rouanne M
…
Arpaia N
Science Translational Medicine
2026-07-22
|
#cancer
#immunotherapy
#microbiome
#antibody
#synthetic biology
|
|
0
|
|
Anti-CD20 B cell depletion is associated with elevated mucosal-originating circulating regulatory IgA B cells in multiple sclerosis.
(science.org)
|
Neziraj T
…
Probstel AK
Science Translational Medicine
2026-07-22
|
#multiple sclerosis
#autoimmunity
#b-cells
#transcriptomics
#immunotherapy
|
|
0
|
|
Tertiary lymphoid structures harbour stem-like tumour-specific T cells.
(nature.com)
|
Afeyan AB
…
Wu CJ
Nature
2026-07-22
|
#immunotherapy
#t cell
#exhaustion
#tumor immunity
#carcinoma
|
|
0
|
|
Blocking the m(6)Am methyltransferase PCIF1 releases STAT1-mediated Th1 immunity to potentiate cancer immunotherapy.
(nature.com)
|
Huang J
…
Li HB
Nature Communications
2026-07-22
|
#immunity
#immunotherapy
#cancer
#epigenetics
#t-cells
|